psoriatic
patients
hypertension
cyclosporin A therapy
treated
months
calcium channel blocker
sustained-release
nifedipine
clinical
antihypertensive effects
adverse events
treatment
drugs
patients
subclinical
hypertensive state
cyclosporin A therapy
systolic
diastolic blood pressures
patients
decreased
weeks
nifedipine therapy
blood pressure
months
adverse events
combined therapy
cyclosporin A
nifedipine
increase
blood urea
nitrogen levels
patients
development
gingival hyperplasia
patients
findings
sustained-release
nifedipine
hypertensive psoriatic
patients
long-term
treatment
cyclosporin A
patients
monitored
gingival hyperplasia
